Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice

European Journal of Pharmacology

Volumn 628, Issue 1-3, 2010, Pages 255-260

  Wang, Zhi hong ^a   Hsu, Cheng chin ^a   Huang, Chien ning ^b   Yin, Mei chin ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aldose reductase; Glycation; Oleanolic acid; Renal CML; Ursolic acid

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; FRUCTOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; IDITOL DEHYDROGENASE; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL; OLEANOLIC ACID; PENTOSIDINE; SORBITOL; URSOLIC ACID;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETES MELLITUS; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; GLUCOSE BLOOD LEVEL; GLYCATION; INSULIN BLOOD LEVEL; KIDNEY MASS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ALDEHYDE REDUCTASE; ANIMALS; DIABETES MELLITUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; L-IDITOL 2-DEHYDROGENASE; LACTOYLGLUTATHIONE LYASE; MALE; MICE; MICE, INBRED BALB C; OLEANOLIC ACID; RNA, MESSENGER; TRITERPENES;

EID: 73649098762     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.019     Document Type: Article

References (32)

1. Beisswenger P.J., Howell S.K., Nelson R.G., Mauer M., and Szwergold B.S. Alpha-oxoaldehyde metabolism and diabetic complications. Biochem. Soc. Trans. 31 (2003) 1358-1363
2. Chaplen F.W., Fahl W.E., and Cameron D.C. Method of determination of free intracellular and extracellular methylglyoxal in animal cells grown in culture. Anal. Biochem. 238 (1996) 171-178
3. Cui T., Li J.Z., Kayahara H., Ma L., Wu L.X., and Nakamura K. Quantification of the polyphenols and triterpene acids in Chinese hawthorn fruit by high-performance liquid chromatography. J. Agric. Food Chem. 54 (2006) 4574-4581
4. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 58 (2000) 3-12
5. Gao D., Li Q., Li Y., Liu Z., Fan Y., Han Z., Li J., and Li K. Antidiabetic potential of oleanolic acid from Liqustrum lucidum Ait. Can. J. Physiol. Pharmacol. 85 (2007) 1076-1083
6. Guerrant G., and Moss C.W. Determination of monosaccharides as aldononitrile, O-methyoxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal. Chem. 56 (1984) 633-638
7. Gugliucci A., and Bendayan M. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39 (1997) 149-160
8. Inagi R., Yamamoto Y., Nangaku M., Usuda N., Okamato K., Kurokawa K., Ypersele C., Yamamoto H., and Miyata T. A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 55 (2006) 356-366
9. Jang S.M., Yee S.T., Choi J., Choi M.S., Do G.M., Jeon S.M., Yeo J., Kim M.J., Seo K.I., and Lee M.K. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int. Immunopharmacol. 9 (2009) 113-119
10. Kalousová M., Zima T., Tesar V., Dusilová-Sulková S., and Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat. Res. 579 (2005) 37-46
11. Kawasaki Y., Fujii J., Miyazawa N., Hoshi A., Okado A., Tano Y., and Taniguchi N. Specific detections of early process of the glycation reaction by fructose and glucose in diabetic rat lens. FEBS Lett. 441 (1998) 116-120
12. Kilhovd B.K., Giardino I., Torjesen P.A., Birkeland K.I., Berg T.J., Thornalley P.J., Brownlee M., and Hanssen K.F. Increased serum levels of the specificAGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism 52 (2003) 163-167
13. Lin C.C., and Yin M.C. Anti-glycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice. Mol. Nutr. Food Res. 52 (2008) 1358-1364
14. Lowry O.H., Rosebrough N.J., and Farr A.L. Protein determination with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
15. Maekawa K., Tanimoto T., Okada S., Suzuki T., Suzuki T., and Yabe-Nishimura C. Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: effects of high glucose and osmotic stress. Brain Res. Mol. Brain Res. 87 (2001) 251-256
16. McLellan A.C., and Thornalley P.J. Glyoxalase activity in human red blood cells fractioned by age. Mech. Aging Dev. 48 (1989) 63-71
17. Miyata T., Taneda S., Kawai R., Ueda Y., Horiuchi S., Hara M., Maeda K., and Monnier V.M. Identification of pentosidine as a native structure for advanced glycation end products in 2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA 93 (1996) 2353-2358
18. Mizisin A.P., Li L., Perello M., Freshwater J.D., Kalichman M.W., Roux L., and Calcutt N.A. Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions. Am. J. Physiol. 270 (1996) 90-97
19. Niikawa M., Hayashi H., Sato T., Nagase H., and Kito H. Isolation of substances from glossy privet (Ligustrum lucidum Ait.) inhibiting the mutagenicity of benzo[a]pyrene in bacteria. Mutat. Res 319 (1993) 1-9
20. Nishinaka T., and Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 31 (2001) 205-216
21. Ovesna Z., Kozics K., and Slamenova D. Protective effects of ursolic acid and oleanolic acid in leukemic cells. Mutat. Res. 600 (2006) 131-137
22. Schleicher E.D., Wagner E., and Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99 (1997) 457-468
23. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P., Thorpe S.R., Onorato J., and Brownlee M. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest. 101 (1998) 1142-1147
24. Takeuchi M., and Yamagishi S. Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo. Med. Hypotheses 63 (2004) 453-455
25. Thornalley P.J. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 31 (2003) 1343-1348
26. Tokita Y., Hirayama Y., Sekikawa A., Kotake H., Toyota T., Miyazawa T., Sawai T., and Oikawa S. Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fed rabbits. J. Atheroscler. Thromb. 12 (2005) 260-267
27. Ulrich H.B. Methods of Enzymatic Analysis. 2nd ed (1974) 569-573
28. Vander Jagt D.L. Mthyylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol. Drug Interact. 23 (2008) 93-124
29. Yin M.C., and Chan K.C. Non-enzymatic antioxidative and antiglycative effects of oleanolic acid and ursolic acid. J. Agric. Food Chem. 55 (2007) 7177-7181
30. Zhang G., Qi Y., Lou Z., Liu C., Wu X., and Chai Y. Determination of oleanolic acid and ursolic acid in cornel by cyclodextrin-modified micellar electrokinetic chromatography. Biomed. Chromatogr. 19 (2005) 529-532
31. Zhou C., Chen K., Sun C., Chen Q., Zhang W., and Li X. Determination of oleanolic acid, ursolic acid and amygdalin in the flower of Eriobotrya japonica Lindl. by HPLC. Biomed. Chromatogr 21 (2007) 755-761
32. Ziyadeh F.N., Mogyorosi A., and Kalluri R. Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp. Nephrol. 5 (1997) 2-9